To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CETN2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
367 supporting clones for gene CETN2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CD691457 normal nasopharynx .a 1 to 259 29 to 286   tiling clone,   258/287
(89 %)
12 diff
(95.9 %id)
BF382312 brain, primitive neuroectoderm .a 6 to 675 1 to 657 F37L D38I L39F F40S D41M ...     655/871
(75 %)
18 diff
(98.0 %id)
BF542114 hypernephroma, Kidney .a 6 to 576 1 to 573       573/852
(67 %)
6 diff
(99.3 %id)
DB491821 hypothalamus .a 10 to 281 1 to 272       272/281
(96 %)
4 diff
(98.6 %id)
DB504025 hypothalamus .a 10 to 489 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
CB995334 placenta, pre-eclamptic placenta .a 17 to 626 5 to 621 Q31H K54N E161K T169D S170Q ...     617/975
(63 %)
18 diff
(98.2 %id)
CB992842 placenta, pre-eclamptic placenta .a 17 to 767 5 to 769 L171P Y172L     765/771
(99 %)
22 diff
(97.2 %id)
CB997405 placenta, pre-eclamptic placenta .a 17 to 777 5 to 772 exact     768/809
(94 %)
19 diff
(97.7 %id)
CD707931 normal nasopharynx .a 19 to 464 16 to 462       447/462
(96 %)
16 diff
(96.6 %id)
FN076162 breast carcinoma .a 23 to 100 1 to 78       78/78
(100 %)
3 diff
(96.2 %id)
CF596138 Stomach, adenocarcinoma .a 23 to 689 1 to 679 N125K L126S K127E R128T V129R ...     679/792
(85 %)
27 diff
(96.6 %id)
CB962196 Blood vessels - aorta, basilar and artery .a 24 to 689 1 to 668 exact     668/765
(87 %)
8 diff
(99.0 %id)
CD104842 Pooled-Skin .a 24 to 721 1 to 710 F5L E156K M166R S170A     710/770
(92 %)
34 diff
(95.6 %id)
BF211105 bone marrow, from chronic myelogenous leukemia .a 25 to 618 1 to 594 F37L D38I L39F F40S D41M ...     594/595
(99 %)
23 diff
(96.2 %id)
BM467047 eye, retinoblastoma .a 25 to 816 10 to 811 exact     802/1146
(69 %)
26 diff
(97.8 %id)
CB963743 Blood vessels - aorta, basilar and artery .a 25 to 723 1 to 706 exact     706/748
(94 %)
12 diff
(98.4 %id)
BF213100 bone marrow, from acute myelogenous leukemia .a 26 to 657 1 to 620 M97N S98V E99*     620/891
(69 %)
17 diff
(98.1 %id)
BC005334 Bladder, carcinoma .a 27 to 1043 1 to 1017 exact available from MGC, AAA   1017/1017
(100 %)
0 diff
(100 %id)
BP232257 muscle .a 27 to 464 1 to 438       438/441
(99 %)
2 diff
(99.6 %id)
DB472662 hippocampus .a 27 to 512 1 to 486       486/486
(100 %)
4 diff
(99.2 %id)
BU155113 bone marrow, from acute myelogenous leukemia .a 27 to 744 1 to 725 K168R T169P S170A L171S Y172I     725/804
(90 %)
13 diff
(98.4 %id)
NM_004344.1   .a 27 to 1112 1 to 1086 exact RefSeq,   1086/1087
(99 %)
5 diff
(99.6 %id)
BP346938 brain .a 27 to 608 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
X72964 umbilical vein .a 27 to 1106 1 to 1080 exact     1080/1087
(99 %)
1 diff
(100.0 %id)
BM849680 stomach .a 28 to 461 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
BC013873 Ovary, adenocarcinoma .a 29 to 1118 1 to 1090 exact tiling clone, available from MGC, AAA   1090/1090
(100 %)
0 diff
(100 %id)
BF245676 brain, glioblastoma .a 29 to 732 1 to 703 F113L D114*     703/876
(80 %)
23 diff
(97.4 %id)
CD693755 normal nasopharynx .a 30 to 409 32 to 412       381/412
(92 %)
7 diff
(98.4 %id)
BP311739 brain .a 30 to 611 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
DA023607   .a 31 to 600 2 to 571 exact capped   570/570
(100 %)
1 diff
(99.9 %id)
AK311940 brain .a 32 to 592 1 to 561 exact     561/561
(100 %)
0 diff
(100 %id)
CD247070 embryonic stem cells, WA01, passage 38 .a 32 to 906 21 to 908 exact     888/909
(97 %)
31 diff
(96.6 %id)
CD695566 normal nasopharynx .a 32 to 380 42 to 390       349/390
(89 %)
6 diff
(98.5 %id)
DA792167 brain .a 33 to 610 2 to 580 D43G G44W T45N G46W T47H ... capped   579/580
(99 %)
2 diff
(99.7 %id)
BI600577 brain, hypothalamus .a 34 to 728 1 to 695 exact     695/695
(100 %)
6 diff
(99.2 %id)
TI_44344532   .a 35 to 750 76 to 790 G46S E141G     715/792
(90 %)
10 diff
(98.8 %id)
TI_44344614   .a 35 to 839 72 to 877 G46S E141G     806/877
(91 %)
17 diff
(98.1 %id)
BI756033 brain .a 36 to 957 1 to 925 exact     925/925
(100 %)
17 diff
(98.2 %id)
CB984772 Pooled-Glandular .a 36 to 621 1 to 587 D152N E161D T169N L171P     587/773
(75 %)
14 diff
(98.2 %id)
TI_57221246   .a 36 to 957 70 to 994 exact     925/994
(93 %)
23 diff
(97.7 %id)
CD685799 normal nasopharynx .a 39 to 668 42 to 670 F37C     631/670
(94 %)
8 diff
(98.9 %id)
AL554338 placenta, Placenta Cot 25-normalized .a 39 to 1096 1 to 1051 exact fully sequenced,   1051/1051
(100 %)
14 diff
(98.7 %id)
TI_45210558   .a 39 to 728 88 to 777 exact     690/777
(88 %)
7 diff
(99.1 %id)
BP375024 umbilical cord .a 39 to 618 1 to 582 exact     582/582
(100 %)
2 diff
(99.7 %id)
BU657664 blood .a 41 to 635 1 to 595 K71E     595/595
(100 %)
5 diff
(99.2 %id)
BI668430 brain, hypothalamus .a 42 to 839 1 to 799 G46S E141G     799/799
(100 %)
12 diff
(98.5 %id)
BI670087 brain, hypothalamus .a 42 to 750 1 to 708 G46S E141G     708/710
(99 %)
8 diff
(98.9 %id)
BG530510 embryonal carcinoma, testis .a 46 to 643 1 to 629 K6N K7E A8G N9K M10H ...     629/824
(76 %)
39 diff
(95.3 %id)
CF596907 ovary .a 46 to 584 1 to 547       547/1059
(51 %)
19 diff
(98.3 %id)
BP208443 cerebellum .a 47 to 626 1 to 580 K124R     580/580
(100 %)
2 diff
(99.7 %id)
CD512347 Pooled-Skin .a 47 to 777 1 to 737 exact     737/742
(99 %)
15 diff
(98.0 %id)
BE742046 adenocarcinoma cell line, ovary .a 48 to 838 1 to 788 F37L D38I L39F F40S D41M ...     788/788
(100 %)
13 diff
(98.4 %id)
DA682551 ovary .a 48 to 599 2 to 553 exact capped   552/552
(100 %)
0 diff
(100 %id)
CN410119 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 49 to 639 7 to 597 exact     591/597
(98 %)
6 diff
(99.0 %id)
BE741302 adenocarcinoma cell line, ovary .a 49 to 710 1 to 662 D152R G153W D154R G155W E156R ...     662/662
(100 %)
2 diff
(99.7 %id)
BF677506 Prostate .a 49 to 745 1 to 685 F37L I76M D77I K78R E79K ...     685/777
(88 %)
27 diff
(96.6 %id)
BF984484 duodenal adenocarcinoma, cell line, small intestine .a 49 to 718 1 to 673 D154T G155M V157R E159V Q160S ...     673/1013
(66 %)
7 diff
(99.4 %id)
BP246561 Kidney .a 50 to 636 1 to 587 T118A M145V     587/587
(100 %)
2 diff
(99.7 %id)
BP247091 Kidney .a 50 to 631 1 to 581 M72*     581/581
(100 %)
7 diff
(98.8 %id)
BE866235 bladder, carcinoma, cell line .a 50 to 581 1 to 533       533/533
(100 %)
2 diff
(99.7 %id)
CB106509 Liver .a 50 to 552 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
CB128735 Liver .a 50 to 575 1 to 526       526/526
(100 %)
0 diff
(100 %id)
DA023995   .a 51 to 606 2 to 558 G46W T47H I48H D49R V50C ... capped   557/557
(100 %)
1 diff
(99.9 %id)
CD237280 Pituitary .a 51 to 733 23 to 702 T45G S158X     680/702
(96 %)
15 diff
(97.9 %id)
DA586841 lung .a 51 to 600 2 to 551 exact capped   550/550
(100 %)
0 diff
(100 %id)
DA684885   .a 51 to 590 2 to 543   capped   542/542
(100 %)
4 diff
(99.3 %id)
DA746841   .a 51 to 628 2 to 579 A11H S12Q S13V S14L Q15S ... capped   578/578
(100 %)
2 diff
(99.7 %id)
DA899343 skeletal muscle .a 51 to 611 2 to 562 exact capped   561/561
(100 %)
0 diff
(100 %id)
DA982047 synovial membrane tissue from rheumatioidarthritis .a 51 to 630 2 to 580 exact capped   579/579
(100 %)
1 diff
(99.9 %id)
CD688503 normal nasopharynx .a 52 to 571 17 to 536       520/536
(97 %)
6 diff
(98.9 %id)
CD690061 normal nasopharynx .a 54 to 664 36 to 646 exact     611/646
(94 %)
10 diff
(98.5 %id)
CD706439 normal nasopharynx .a 54 to 659 18 to 623 L133S     606/623
(97 %)
7 diff
(98.9 %id)
AV733516 pheochromocytoma .a 54 to 830 7 to 780 exact     774/785
(98 %)
17 diff
(97.9 %id)
BU943090 mixed (pool of 40 RNAs) .a 54 to 794 1 to 755 exact     755/767
(98 %)
18 diff
(97.7 %id)
CB962932 Blood vessels - aorta, basilar and artery .a 55 to 713 1 to 664 exact     664/744
(89 %)
9 diff
(98.8 %id)
CB999878 Pooled-Skin .a 55 to 711 1 to 665 L137P T138D D139*     665/736
(90 %)
27 diff
(96.4 %id)
DA895169 skeletal muscle .a 55 to 596 2 to 545 D43G G44W T45N G46L T47A ... capped   544/544
(100 %)
3 diff
(99.5 %id)
DN997982 breast cancer, Mammary gland (cancer tissue) .a 55 to 637 1 to 583 exact     583/583
(100 %)
4 diff
(99.4 %id)
BF670338 muscle (skeletal) .a 56 to 759 1 to 703 N125K L126S K127E R128T V129R ...     701/891
(78 %)
18 diff
(98.0 %id)
DT219397 brain .a 57 to 772 1 to 716 E99G     716/716
(100 %)
1 diff
(99.9 %id)
BJ994786 hepatoblastoma .a 57 to 628 1 to 573 E156R V157G S158Q E159* fully sequenced,   573/573
(100 %)
1 diff
(99.9 %id)
BG527092 lung, mucoepidermoid carcinoma .a 57 to 693 1 to 650 Q143P E144G M145H I146*     645/657
(98 %)
8 diff
(98.8 %id)
BE958578 brain, primitive neuroectoderm .a 58 to 720 1 to 660 F86L G87V D88T L90N T91C ...     660/747
(88 %)
34 diff
(95.5 %id)
BF208865 bladder, carcinoma, cell line .a 59 to 766 1 to 712 F37L D38I L39F F40S D41M ...     712/795
(89 %)
58 diff
(92.8 %id)
BF219348 brain, glioblastoma .a 60 to 678 1 to 619 F86L F113L D114*     619/620
(99 %)
13 diff
(98.0 %id)
BF978941 melanotic melanoma, high MDR, skin .a 60 to 758 2 to 688 F86L G87V D88T L90*     687/881
(77 %)
22 diff
(97.6 %id)
BM927115 brain .a 60 to 1052 1 to 1000 exact     1000/1039
(96 %)
17 diff
(98.4 %id)
BP196514 adrenal gland .a 61 to 640 1 to 581 exact     581/581
(100 %)
3 diff
(99.5 %id)
BQ278662 adenocarcinoma, cell line, breast .a 61 to 844 1 to 804 exact     804/1116
(72 %)
13 diff
(98.9 %id)
BU146639 dorsal root ganglia .a 61 to 916 11 to 879 exact     869/881
(98 %)
22 diff
(97.6 %id)
CD104085 Pooled-Skin .a 61 to 734 1 to 681 E161D F162S L163C R164A I165S ...     681/772
(88 %)
16 diff
(98.0 %id)
BP351636   .a 61 to 626 1 to 566 exact     566/582
(97 %)
2 diff
(99.7 %id)
BF247903 hypernephroma, Kidney .a 64 to 779 1 to 709 I69L G119W K120E I121D S122F ...     711/849
(83 %)
36 diff
(95.8 %id)
BM786173 stomach .a 64 to 730 1 to 667 exact     667/667
(100 %)
0 diff
(100 %id)
BE797790 lung, small cell carcinoma .a 72 to 805 25 to 753       732/756
(96 %)
16 diff
(97.9 %id)
BT007256   .a 74 to 591 1 to 518       518/519
(99 %)
1 diff
(99.9 %id)
CV023103 mixed .a 74 to 591 1 to 518       518/585
(88 %)
3 diff
(99.5 %id)
BM544063 ovary (pool of 3) .a 76 to 1044 37 to 1016       981/1100
(89 %)
22 diff
(98.0 %id)
TI_57219304   .a 78 to 982 59 to 963       905/963
(93 %)
22 diff
(97.8 %id)
BM460861 leiomyosarcoma, uterus .a 79 to 626 170 to 720       551/1258
(43 %)
13 diff
(99.0 %id)
BF973090 leiomyosarcoma cell line, uterus .a 80 to 768 1 to 696       696/1044
(66 %)
32 diff
(97.0 %id)
BG337523 leiomyosarcoma cell line, uterus .a 80 to 866 1 to 776       776/1033
(75 %)
22 diff
(97.9 %id)
BQ068273 brain .a 80 to 885 1 to 811       811/937
(86 %)
6 diff
(99.4 %id)
BX105552 lung .a 81 to 862 1 to 782       782/782
(100 %)
1 diff
(99.9 %id)
W04882 lung .a 81 to 557 1 to 473       473/474
(99 %)
8 diff
(98.4 %id)
AL559603 T cells from T cell leukemia .a 85 to 1096 1 to 1008   fully sequenced,   1008/1008
(100 %)
10 diff
(99.1 %id)
D56385   .a 85 to 644 1 to 564       564/565
(99 %)
7 diff
(98.8 %id)
AV723510 hypothalamus .a 85 to 700 1 to 607       607/607
(100 %)
14 diff
(97.7 %id)
BG163770 hypernephroma, cell line, Kidney .a 85 to 870 1 to 779       779/1127
(69 %)
31 diff
(97.3 %id)
BI752301 brain .a 85 to 982 1 to 898       898/898
(100 %)
16 diff
(98.3 %id)
CN410118 embryonic stem cells, DMSO-treated H9 cellline .a 95 to 577 1 to 483       483/483
(100 %)
4 diff
(99.2 %id)
BE790111 large cell carcinoma, lung .a 96 to 899 1 to 797       797/862
(92 %)
29 diff
(96.7 %id)
BE293433 adenocarcinoma cell line, colon .a 98 to 604 523 to 18       506/523
(96 %)
2 diff
(99.7 %id)
BE293715 adenocarcinoma cell line, colon .a 98 to 610 518 to 6       513/518
(99 %)
0 diff
(100 %id)
CN410121 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 100 to 714 1 to 615       615/615
(100 %)
0 diff
(100 %id)
AI681691 carcinoid, lung .a 100 to 606 1 to 507     Submitted on the opposite strand 507/507
(100 %)
3 diff
(99.5 %id)
BM794962 Ascites, stomach .a 103 to 700 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BG121897 adenocarcinoma, cell line, Liver .a 115 to 909 7 to 797       791/818
(96 %)
27 diff
(96.7 %id)
BM508174 insulinoma, Pancreas .a 115 to 702 1 to 588     Submitted on the opposite strand 588/588
(100 %)
0 diff
(100 %id)
BQ723318 sympathetic trunk .a 123 to 755 1 to 636       636/964
(65 %)
14 diff
(98.6 %id)
BG537549 lung .a 130 to 906 1 to 798       798/803
(99 %)
8 diff
(99.1 %id)
CN410122 embryonic stem cells, cell lines H1, H7, andH9 .a 143 to 795 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
W00474 melanocyte .a 150 to 580 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
BQ669007 epidermoid carcinoma, cell line, salivary gland .a 153 to 1106 1 to 958       958/985
(97 %)
16 diff
(98.4 %id)
BG430439 Kidney .a 169 to 762 1 to 609       609/888
(68 %)
25 diff
(97.2 %id)
BI043582 ovary .a 200 to 769 580 to 19       562/596
(94 %)
3 diff
(99.5 %id)
BI044801 ovary .a 200 to 720 9 to 530       522/530
(98 %)
9 diff
(98.4 %id)
BQ345762 nervous_tumor .a 200 to 721 31 to 552       522/554
(94 %)
23 diff
(95.9 %id)
BQ346001 nervous_tumor .a 200 to 743 543 to 1       543/564
(96 %)
9 diff
(98.5 %id)
CB215841 normal endometrium, late proliferativephase, cycle day 13, uterus .a 206 to 805 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BQ345565 nervous_tumor .a 210 to 733 518 to 4       515/518
(99 %)
0 diff
(100 %id)
AA283060 germinal center B cell .a 224 to 673 1 to 450   fully sequenced,   450/450
(100 %)
0 diff
(100 %id)
AI681294 carcinoid, lung .a 234 to 1103 871 to 1       871/875
(99 %)
21 diff
(97.6 %id)
BM854088 Ascites, stomach .a 238 to 816 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BQ345916 nervous_tumor .a 241 to 760 9 to 540       545/540
(100 %)
59 diff
(89.1 %id)
BG167007 hypernephroma, cell line, Kidney .a 241 to 1032 1 to 789       789/953
(82 %)
18 diff
(98.2 %id)
TI_149297585   .a 242 to 1104 934 to 80   AAA   855/965
(88 %)
12 diff
(98.8 %id)
TI_154062200   .a 242 to 1111 962 to 98   AAA   865/1010
(85 %)
16 diff
(98.5 %id)
CD618401   .a 246 to 977 8 to 740       733/744
(98 %)
11 diff
(98.6 %id)
CD618403   .a 246 to 952 8 to 712       704/712
(98 %)
15 diff
(97.9 %id)
TI_149311217   .a 262 to 1104 934 to 105   AAA   830/940
(88 %)
18 diff
(98.1 %id)
W21362 lung .a 274 to 479 1 to 208       208/208
(100 %)
4 diff
(98.1 %id)
TI_149313138   .a 276 to 1110 927 to 96   AAA   832/999
(83 %)
9 diff
(99.1 %id)
BQ227846 epithelioid carcinoma, Pancreas .a 278 to 1103 1 to 830       830/887
(93 %)
8 diff
(99.1 %id)
BP200952 amygdala .a 285 to 871 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
CK002661 brain/CNS, Bulk tissue from Human Spinal cord .a 294 to 952 1 to 654       654/656
(99 %)
9 diff
(98.7 %id)
BQ930131 leiomyosarcoma, uterus .a 296 to 1103 1 to 810       810/816
(99 %)
9 diff
(98.9 %id)
BE694176 breast .a 299 to 650 15 to 366       352/366
(96 %)
6 diff
(98.4 %id)
Z30203   .a 301 to 636 1 to 335       335/335
(100 %)
2 diff
(99.5 %id)
BM854779 Ascites, stomach .a 311 to 1050 1 to 740       740/740
(100 %)
0 diff
(100 %id)
T29090 lung .a 312 to 689 1 to 378       378/380
(99 %)
4 diff
(99.0 %id)
BQ345769 nervous_tumor .a 315 to 769 466 to 13       454/468
(97 %)
3 diff
(99.4 %id)
BG696707 skin .a 317 to 1170 1 to 853       853/853
(100 %)
11 diff
(98.8 %id)
AI694310 pooled .a 319 to 1106 787 to 2       786/787
(99 %)
8 diff
(99.0 %id)
AW951106   .a 325 to 888 1 to 565       565/565
(100 %)
5 diff
(99.2 %id)
BQ346057 nervous_tumor .a 327 to 607 25 to 308       286/309
(92 %)
19 diff
(93.9 %id)
AL559625 T cells from T cell leukemia .a 334 to 1070 737 to 1   fully sequenced,   737/737
(100 %)
2 diff
(99.8 %id)
AI457787 carcinoid, lung .a 344 to 897 1 to 554     Submitted on the opposite strand 554/554
(100 %)
0 diff
(100 %id)
CB241031 Human Lung Epithelial cells, lung .a 344 to 1104 779 to 19   AAA   761/761
(100 %)
0 diff
(100 %id)
BM982619 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 349 to 1104 772 to 19   AAA   754/754
(100 %)
1 diff
(99.9 %id)
BM699040 eye, fetal eyes .a 361 to 945 1 to 585       585/585
(100 %)
0 diff
(100 %id)
TI_149279908   .a 364 to 1110 832 to 91   AAA   742/1095
(67 %)
12 diff
(99.0 %id)
TI_149305236   .a 365 to 1104 883 to 144       740/1050
(70 %)
8 diff
(99.3 %id)
CD618399   .a 368 to 1106 753 to 17       737/753
(97 %)
3 diff
(99.7 %id)
AI208850   .a 372 to 780 412 to 4       409/413
(99 %)
2 diff
(99.6 %id)
AI640172 Kidney .a 372 to 1104 734 to 1       734/735
(99 %)
17 diff
(97.7 %id)
CF541185 lung .a 376 to 1110 753 to 19   AAA   735/735
(100 %)
4 diff
(99.5 %id)
BI044033 ovary .a 382 to 769 400 to 12       389/400
(97 %)
2 diff
(99.5 %id)
BU689272 lung .a 388 to 1104 734 to 19   AAA   716/716
(100 %)
2 diff
(99.8 %id)
AI670881 Kidney .a 392 to 1104 711 to 1       711/718
(99 %)
14 diff
(98.1 %id)
BE090147 breast .a 393 to 832 465 to 26     Submitted on the opposite strand 440/465
(94 %)
0 diff
(100 %id)
AI074606 liver and spleen .a 393 to 1106 714 to 1       714/715
(99 %)
8 diff
(98.9 %id)
BQ018702 lung, Metastatic Chondrosarcoma .a 399 to 1104 723 to 19   AAA   705/705
(100 %)
2 diff
(99.8 %id)
CA421092 Bone, Enchondroma cell line .a 403 to 1111 727 to 19   AAA   709/709
(100 %)
2 diff
(99.8 %id)
TI_154050586   .a 405 to 1110 813 to 108   AAA   706/947
(74 %)
7 diff
(99.3 %id)
AI909822 breast .a 410 to 875 490 to 22       469/526
(89 %)
5 diff
(99.1 %id)
BF940039 brain, glioblastoma (pooled) .a 425 to 1104 680 to 1       680/680
(100 %)
5 diff
(99.3 %id)
BU622454 cell lines, Chondrosarcoma .a 426 to 1104 697 to 19   AAA   679/679
(100 %)
1 diff
(99.9 %id)
TI_154035708   .a 430 to 1104 751 to 82   AAA   670/799
(83 %)
16 diff
(98.0 %id)
AI858065 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 431 to 1104 673 to 1       673/674
(99 %)
13 diff
(98.1 %id)
CD618404   .a 455 to 1104 704 to 54   AAA   651/651
(100 %)
7 diff
(99.0 %id)
BE762975 nervous_tumor .a 457 to 828 5 to 376       372/376
(98 %)
9 diff
(97.7 %id)
AA614862 breast .a 459 to 863 405 to 1       405/406
(99 %)
2 diff
(99.6 %id)
BE178819 head_neck .a 461 to 696 244 to 9     Submitted on the opposite strand 236/244
(96 %)
0 diff
(100 %id)
BU626094 cell lines, Enchondroma .a 461 to 1104 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
AI681393 carcinoid, lung .a 462 to 1104 654 to 11   AAA   644/644
(100 %)
2 diff
(99.7 %id)
BU632416 cell lines, Chondrosarcoma .a 463 to 1111 666 to 19   AAA   648/648
(100 %)
2 diff
(99.7 %id)
CA414097 Chondrosarcoma Grade II, Left Pelvis .a 465 to 1110 664 to 19   AAA   646/646
(100 %)
6 diff
(99.1 %id)
TI_149274267   .a 471 to 1104 196 to 827   AAA Submitted on the opposite strand 632/827
(76 %)
22 diff
(97.4 %id)
BM968445 lung, Primary Lung Epithelial Cells .a 471 to 954 79 to 562     Submitted on the opposite strand 484/544
(88 %)
14 diff
(97.5 %id)
BM969785 lung, Primary Lung Epithelial Cells .a 475 to 1110 652 to 19   AAA   634/634
(100 %)
5 diff
(99.3 %id)
AI761953 Kidney .a 482 to 1104 619 to 1       619/619
(100 %)
9 diff
(98.6 %id)
BM697804 eye, fetal eyes .a 482 to 1044 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
BQ774330 Chondrosarcoma Grade II, Left Pelvis .a 488 to 1104 635 to 19   AAA   617/617
(100 %)
9 diff
(98.6 %id)
BU676671 lung, Primary Lung Epithelial Cells .a 492 to 1104 629 to 19   AAA   611/611
(100 %)
5 diff
(99.2 %id)
AI670873 Kidney .a 498 to 1104 607 to 1       607/611
(99 %)
11 diff
(98.2 %id)
AI400174 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 501 to 1106 610 to 6       605/614
(98 %)
0 diff
(100 %id)
AI910439 colon, colon tumor, RER+ .a 501 to 1104 602 to 1       602/603
(99 %)
5 diff
(99.2 %id)
AI991986 anaplastic oligodendroglioma, brain .a 501 to 1104 610 to 11   AAA   600/607
(98 %)
13 diff
(97.9 %id)
TI_149275475   .a 501 to 1104 726 to 125   AAA   602/942
(63 %)
5 diff
(99.5 %id)
AA460091   .a 503 to 807 1 to 306   fully sequenced,   306/306
(100 %)
2 diff
(99.4 %id)
FN077540 breast carcinoma .a 506 to 569 1 to 63       63/63
(100 %)
4 diff
(93.7 %id)
AI431584 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 506 to 1059 554 to 1       554/554
(100 %)
2 diff
(99.7 %id)
FN172561 breast carcinoma .a 507 to 589 83 to 1     Submitted on the opposite strand 83/83
(100 %)
0 diff
(100 %id)
FN155238 breast carcinoma .a 508 to 593 84 to 1     Submitted on the opposite strand 84/84
(100 %)
2 diff
(97.7 %id)
AI089029 brain, glioblastoma (pooled) .a 509 to 1106 599 to 2       598/599
(99 %)
0 diff
(100 %id)
BE772285 prostate_tumor .a 511 to 867 368 to 15       354/368
(96 %)
0 diff
(100 %id)
BE048642 Kidney .a 514 to 1106 596 to 4       593/596
(99 %)
0 diff
(100 %id)
AW614075 Kidney .a 521 to 1104 584 to 1       584/584
(100 %)
2 diff
(99.7 %id)
BQ029690 lung, Metastatic Chondrosarcoma .a 523 to 1104 600 to 19   AAA   582/582
(100 %)
1 diff
(99.9 %id)
AW262850 brain, three pooled meningiomas .a 530 to 1104 575 to 1       575/575
(100 %)
2 diff
(99.7 %id)
T64539 lung .a 533 to 852 1 to 326       326/332
(98 %)
7 diff
(97.9 %id)
BG532126 embryonal carcinoma, testis .a 538 to 1369 1 to 824       824/847
(97 %)
24 diff
(97.2 %id)
CK823691 insulinoma, Pancreas .a 561 to 1106 568 to 23     Submitted on the opposite strand 546/568
(96 %)
0 diff
(100 %id)
TI_149275415   .a 562 to 1104 617 to 78   AAA   540/696
(77 %)
3 diff
(99.6 %id)
BU676633 lung, Primary Lung Epithelial Cells .a 562 to 1104 558 to 19   AAA   540/557
(96 %)
3 diff
(99.5 %id)
BM511032 insulinoma, Pancreas .a 577 to 1080 1 to 504       504/504
(100 %)
8 diff
(98.5 %id)
AL577079 placenta, Placenta Cot 25-normalized .a 587 to 1069 482 to 1   fully sequenced,   482/482
(100 %)
14 diff
(97.1 %id)
FN174122 breast carcinoma .a 598 to 702 106 to 1     Submitted on the opposite strand 106/106
(100 %)
3 diff
(97.2 %id)
AA582224 Kidney, kidney tumor .a 598 to 1106 511 to 3       509/512
(99 %)
0 diff
(100 %id)
BI495201 cochlea, ear .a 601 to 1101 6 to 506     Submitted on the opposite strand 501/508
(98 %)
6 diff
(98.9 %id)
BI495202 cochlea, ear .a 601 to 1101 503 to 3     Submitted on the opposite strand 501/513
(97 %)
0 diff
(100 %id)
FN155788 breast carcinoma .a 604 to 709 105 to 1     Submitted on the opposite strand 105/108
(97 %)
1 diff
(99.1 %id)
BF197587 Kidney .a 604 to 1106 503 to 1       503/503
(100 %)
0 diff
(100 %id)
BM510354 insulinoma, Pancreas .a 606 to 1106 523 to 23     Submitted on the opposite strand 501/523
(95 %)
0 diff
(100 %id)
BJ994787 hepatoblastoma .a 612 to 1075 464 to 1   fully sequenced,   464/464
(100 %)
0 diff
(100 %id)
BM703099 eye, human retina .a 619 to 1059 1 to 441       441/441
(100 %)
0 diff
(100 %id)
AV733272 pheochromocytoma .a 623 to 1104 1 to 482   AAA   482/482
(100 %)
0 diff
(100 %id)
TI_157613526   .a 624 to 1104 562 to 82   AAA   481/481
(100 %)
5 diff
(99.0 %id)
BP393323 pancreatic islet .a 626 to 1104 1 to 479     Submitted on the opposite strand 479/479
(100 %)
2 diff
(99.6 %id)
FN106154 breast carcinoma .a 631 to 745 1 to 119       119/122
(97 %)
5 diff
(96.0 %id)
AA632011 breast .a 634 to 1104 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AI769114 pooled .a 636 to 1106 476 to 8       469/476
(98 %)
0 diff
(100 %id)
AI091029 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 640 to 1104 465 to 1       465/465
(100 %)
1 diff
(99.8 %id)
BQ346037 nervous_tumor .a 643 to 760 115 to 2       114/115
(99 %)
0 diff
(100 %id)
AA282970 germinal center B cell .a 643 to 1112 470 to 1   fully sequenced,   470/470
(100 %)
1 diff
(99.8 %id)
AI375169 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 647 to 1106 463 to 4       460/463
(99 %)
0 diff
(100 %id)
DB541417 hippocampus .a 650 to 1104 1 to 455     Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
AI400216 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 650 to 1106 456 to 1       456/456
(100 %)
5 diff
(99.0 %id)
DB575277 hypothalamus .a 652 to 1104 1 to 453     Submitted on the opposite strand 453/453
(100 %)
1 diff
(99.8 %id)
AA782032   .a 655 to 1106 454 to 4       451/454
(99 %)
0 diff
(100 %id)
N70581 lung .a 661 to 1110 454 to 2       453/454
(99 %)
0 diff
(100 %id)
CN410120 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 673 to 1051 1 to 379       379/379
(100 %)
10 diff
(97.4 %id)
AI633913 pooled germ cell tumors .a 675 to 1104 427 to 1       427/429
(99 %)
6 diff
(98.7 %id)
AW044700 pooled .a 678 to 1104 445 to 19   AAA   427/427
(100 %)
5 diff
(98.9 %id)
DB539257 hippocampus .a 680 to 1104 1 to 427     Submitted on the opposite strand 427/427
(100 %)
12 diff
(97.2 %id)
CD618402   .a 684 to 1103 648 to 230       419/425
(98 %)
0 diff
(100 %id)
AI129124 senescent fibroblast .a 695 to 1104 421 to 12   AAA   410/410
(100 %)
1 diff
(99.8 %id)
AI624690 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 697 to 1106 411 to 2       410/411
(99 %)
0 diff
(100 %id)
AI799764 Prostate .a 708 to 1104 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
DB562641 hypothalamus .a 711 to 1104 1 to 394     Submitted on the opposite strand 394/394
(100 %)
5 diff
(98.8 %id)
FN152613 breast carcinoma .a 714 to 827 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
CD106258 brain, Pituitary .a 722 to 1104 1 to 383   AAA   383/383
(100 %)
0 diff
(100 %id)
CA444111 Fibrosarcoma .a 725 to 1104 398 to 19   AAA   380/380
(100 %)
0 diff
(100 %id)
FN093397 breast carcinoma .a 727 to 786 1 to 60       60/61
(98 %)
1 diff
(98.4 %id)
BE503032 carcinoid, lung .a 736 to 1092 1 to 357     Submitted on the opposite strand 357/357
(100 %)
0 diff
(100 %id)
AA916363 breast .a 746 to 1104 359 to 1       359/359
(100 %)
0 diff
(100 %id)
BE182933 head_neck .a 747 to 880 1 to 134       134/134
(100 %)
0 diff
(100 %id)
FN118764 breast carcinoma .a 753 to 843 1 to 91       91/92
(98 %)
2 diff
(97.9 %id)
AI373064 Kidney .a 756 to 1104 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AA492546 colon .a 758 to 1110 354 to 2       353/354
(99 %)
0 diff
(100 %id)
AW772272 Kidney .a 763 to 1105 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BM855761 stomach .a 769 to 1118 1 to 350   AAA   350/350
(100 %)
0 diff
(100 %id)
AA987867 Kidney, kidney tumor .a 773 to 1104 353 to 22   AAA   332/332
(100 %)
0 diff
(100 %id)
AA459997   .a 777 to 1104 339 to 12   fully sequenced, AAA   328/328
(100 %)
0 diff
(100 %id)
AI368642 anaplastic oligodendroglioma, brain .a 782 to 1104 323 to 1       323/323
(100 %)
0 diff
(100 %id)
DB510668 testis .a 783 to 1104 1 to 322   AAA Submitted on the opposite strand 322/322
(100 %)
0 diff
(100 %id)
FN142395 breast carcinoma .a 784 to 891 106 to 1     Submitted on the opposite strand 106/106
(100 %)
4 diff
(96.3 %id)
AW243721 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 786 to 1104 319 to 1       319/319
(100 %)
0 diff
(100 %id)
N72193 melanocyte .a 792 to 1104 315 to 1       315/413
(76 %)
2 diff
(99.6 %id)
AW015455   .a 798 to 1104 325 to 19   AAA   307/307
(100 %)
3 diff
(99.1 %id)
BU679436 lung, Primary Lung Epithelial Cells .a 798 to 1104 325 to 19   AAA   307/339
(90 %)
5 diff
(98.6 %id)
CD679394 eye, Trabecular meshwork .a 807 to 1417 1 to 611       611/611
(100 %)
0 diff
(100 %id)
FN083854 breast carcinoma .a 811 to 903 91 to 1     Submitted on the opposite strand 91/92
(98 %)
4 diff
(95.7 %id)
AW007571 colon .a 816 to 1107 300 to 8       293/300
(97 %)
0 diff
(100 %id)
TI_149271919   .a 816 to 1422 712 to 109   AAA   604/819
(73 %)
3 diff
(99.7 %id)
BU674731 lung, Primary Lung Epithelial Cells .a 816 to 1422 622 to 19   AAA   604/619
(97 %)
3 diff
(99.6 %id)
FN092186 breast carcinoma .a 818 to 911 92 to 1     Submitted on the opposite strand 92/92
(100 %)
2 diff
(97.9 %id)
BF154709 breast_normal .a 829 to 999 222 to 52       171/222
(77 %)
0 diff
(100 %id)
AI868673 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 831 to 1106 281 to 6       276/281
(98 %)
0 diff
(100 %id)
C20558   .a 839 to 1118 1 to 280       280/280
(100 %)
0 diff
(100 %id)
D45517 lung .a 839 to 1120 1 to 282     Submitted on the opposite strand 282/283
(99 %)
1 diff
(99.7 %id)
FN175200 breast carcinoma .a 844 to 944 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
FN055103 breast carcinoma .a 845 to 898 54 to 1     Submitted on the opposite strand 54/55
(98 %)
1 diff
(98.2 %id)
AI928680 anaplastic oligodendroglioma, brain .a 849 to 1102 254 to 1       254/254
(100 %)
2 diff
(99.3 %id)
AI130836 heart .a 850 to 1104 271 to 17   AAA   255/255
(100 %)
5 diff
(98.1 %id)
FN117755 breast carcinoma .a 854 to 947 1 to 94       94/94
(100 %)
0 diff
(100 %id)
BG993639 head_neck .a 856 to 1070 216 to 3       214/218
(98 %)
0 diff
(100 %id)
FN112542 breast carcinoma .a 856 to 953 97 to 1     Submitted on the opposite strand 97/97
(100 %)
1 diff
(99.0 %id)
FN095694 breast carcinoma .a 859 to 941 82 to 3     Submitted on the opposite strand 80/90
(88 %)
0 diff
(100 %id)
AI963630 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 861 to 1043 185 to 3       183/185
(98 %)
0 diff
(100 %id)
AI191010 lung .a 863 to 1104 252 to 11   AAA   242/242
(100 %)
2 diff
(99.2 %id)
FN158896 breast carcinoma .a 869 to 964 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
AA834469 epithelium (cell line), Prostate .a 884 to 1105 222 to 1       222/222
(100 %)
0 diff
(100 %id)
FN163300 breast carcinoma .a 889 to 968 1 to 80       80/90
(88 %)
1 diff
(98.9 %id)
BG179242 adenocarcinoma, cell line, Prostate .a 893 to 1626 1 to 731   tiling clone,   731/1129
(64 %)
21 diff
(98.2 %id)
T65962 lung .a 914 to 1105 193 to 1       193/193
(100 %)
1 diff
(99.5 %id)
FN166435 breast carcinoma .a 918 to 1022 106 to 1     Submitted on the opposite strand 106/106
(100 %)
2 diff
(98.2 %id)
FN058449 breast carcinoma .a 924 to 1033 1 to 110       110/110
(100 %)
0 diff
(100 %id)
FN068000 breast carcinoma .a 925 to 1036 1 to 113       113/113
(100 %)
3 diff
(97.4 %id)
N93012 lung .a 931 to 1106 177 to 2       176/181
(97 %)
0 diff
(100 %id)
N67416 cochlea, ear .a 933 to 1105 173 to 1       173/173
(100 %)
0 diff
(100 %id)
GD142556   .a 937 to 1104 1 to 168   AAA   168/168
(100 %)
1 diff
(99.5 %id)
FN087119 breast carcinoma .a 970 to 1030 61 to 1     Submitted on the opposite strand 61/62
(98 %)
2 diff
(96.8 %id)
AW771495 Kidney .a 975 to 1425 451 to 1       451/451
(100 %)
3 diff
(99.4 %id)
AW271309 Kidney .a 977 to 1413 439 to 3       437/439
(99 %)
0 diff
(100 %id)
AI361096 brain, glioblastoma (pooled) .a 980 to 1439 466 to 7       460/466
(98 %)
0 diff
(100 %id)
BI494838 cochlea, ear .a 983 to 1101 118 to 1       118/125
(94 %)
1 diff
(99.2 %id)
FN046650 breast carcinoma .a 1005 to 1103 1 to 99       99/101
(98 %)
1 diff
(99.1 %id)
FN084162 breast carcinoma .a 1006 to 1103 1 to 96       96/98
(97 %)
5 diff
(94.9 %id)
AI025418 parathyroid gland, parathyroid tumor .a 1021 to 1106 90 to 5       86/90
(95 %)
0 diff
(100 %id)
FN177053 breast carcinoma .a 1025 to 1101 76 to 3     Submitted on the opposite strand 74/79
(93 %)
0 diff
(100 %id)
FN123828 breast carcinoma .a 1026 to 1108 1 to 83       83/86
(96 %)
2 diff
(97.7 %id)
FN047787 breast carcinoma .a 1037 to 1101 1 to 65       65/67
(97 %)
1 diff
(98.6 %id)
AI423700 brain, glioblastoma (pooled) .a 1121 to 1439 319 to 1       319/319
(100 %)
0 diff
(100 %id)
FN109353 breast carcinoma .a 1137 to 1242 110 to 4     Submitted on the opposite strand 107/112
(95 %)
0 diff
(100 %id)
BQ029955 lung, Metastatic Chondrosarcoma .a 1145 to 1460 334 to 19   AAA   316/316
(100 %)
3 diff
(99.1 %id)
AI762323 Kidney .a 1169 to 1413 245 to 1       245/245
(100 %)
1 diff
(99.6 %id)
BE090534 breast .a 1546 to 2007 1 to 461   tiling clone,   461/461
(100 %)
8 diff
(98.3 %id)
AA325440 brain, cerebellum .a 1704 to 1959 1 to 256   tiling clone,   256/256
(100 %)
2 diff
(99.3 %id)
DB027639 testis .b 1 to 565 2 to 566 exact tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
R96106 pineal gland .b 20 to 410 1 to 398       400/398
(100 %)
10 diff
(97.5 %id)
AA312107   .b 25 to 423 1 to 403       403/403
(100 %)
4 diff
(99.1 %id)
CD700659 normal nasopharynx .b 27 to 470 28 to 472       445/472
(94 %)
7 diff
(98.6 %id)
CD698733 normal nasopharynx .b 33 to 497 34 to 499       466/499
(93 %)
8 diff
(98.4 %id)
DB445655 testis .b 33 to 458 1 to 426       426/426
(100 %)
0 diff
(100 %id)
BE566653 bladder, carcinoma, cell line .b 46 to 303 1 to 262       262/265
(98 %)
10 diff
(96.3 %id)
CN483785 eye .b 48 to 456 1 to 409       409/409
(100 %)
0 diff
(100 %id)
BG927078 cartilage .b 49 to 449 88 to 488       404/420
(96 %)
10 diff
(97.7 %id)
AU100004   .b 49 to 324 25 to 300       278/300
(92 %)
14 diff
(95.4 %id)
FN136584 breast carcinoma .b 50 to 153 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
BM466286 eye, retinoblastoma .b 50 to 270 1 to 221       221/221
(100 %)
1 diff
(99.6 %id)
CB158225 Liver .b 54 to 506 1 to 453       453/453
(100 %)
0 diff
(100 %id)
AA372905 colon .b 55 to 291 1 to 244       244/245
(99 %)
9 diff
(96.4 %id)
AA379970 skin .b 69 to 392 1 to 324       324/324
(100 %)
0 diff
(100 %id)
AA383564 testis .b 69 to 396 1 to 328       328/337
(97 %)
7 diff
(98.0 %id)
BE720406 head_neck .b 70 to 386 1 to 315       315/315
(100 %)
6 diff
(98.1 %id)
FN122186 breast carcinoma .b 94 to 189 95 to 1     Submitted on the opposite strand 95/97
(97 %)
1 diff
(99.0 %id)
BF224233 carcinoid, lung .b 97 to 472 1 to 376     Submitted on the opposite strand 376/388
(96 %)
21 diff
(94.6 %id)
FN130559 breast carcinoma .b 106 to 203 1 to 100       100/100
(100 %)
3 diff
(97.0 %id)
AA248547   .b 118 to 329 1 to 206       206/206
(100 %)
15 diff
(92.8 %id)
AW612235 carcinoid, lung .b 118 to 511 1 to 394     Submitted on the opposite strand 394/394
(100 %)
5 diff
(98.8 %id)
FN128940 breast carcinoma .b 135 to 233 1 to 100       100/107
(93 %)
2 diff
(98.2 %id)
FN061196 breast carcinoma .b 171 to 286 113 to 1     Submitted on the opposite strand 113/113
(100 %)
3 diff
(97.4 %id)
BQ345545 nervous_tumor .b 177 to 385 11 to 221       211/245
(86 %)
15 diff
(93.9 %id)
BI017253 lung_tumor .b 181 to 417 19 to 253       235/253
(92 %)
15 diff
(94.1 %id)
BF910106 uterus_tumor .b 214 to 475 8 to 262       253/276
(91 %)
11 diff
(96.1 %id)
BQ345750 nervous_tumor .b 214 to 493 14 to 303       303/303
(100 %)
59 diff
(80.6 %id)
CD618400   .b 219 to 418 8 to 207       200/207
(96 %)
6 diff
(97.2 %id)
AW364315 denis_drash .b 251 to 464 233 to 24       210/247
(85 %)
4 diff
(98.4 %id)
DN912316   .b 276 to 437 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
FN068813 breast carcinoma .b 281 to 337 69 to 13     Submitted on the opposite strand 57/69
(82 %)
0 diff
(100 %id)
FN142139 breast carcinoma .b 357 to 410 1 to 54       54/54
(100 %)
0 diff
(100 %id)
FN159521 breast carcinoma .b 357 to 444 89 to 1     Submitted on the opposite strand 89/92
(96 %)
1 diff
(99.0 %id)
FN052108 breast carcinoma .b 375 to 442 68 to 1     Submitted on the opposite strand 68/69
(98 %)
0 diff
(100 %id)
FN079313 breast carcinoma .b 392 to 491 102 to 1     Submitted on the opposite strand 102/102
(100 %)
2 diff
(98.1 %id)
FN063527 breast carcinoma .b 428 to 514 87 to 1     Submitted on the opposite strand 87/87
(100 %)
0 diff
(100 %id)
CD684815 normal nasopharynx .c 1 to 524 30 to 553 K74T tiling clone,   531/553
(96 %)
9 diff
(98.4 %id)
CR593366 Placenta Cot 25-normalized .d 1 to 1062 1 to 1062 exact tiling clone,   1062/1062
(100 %)
0 diff
(100 %id)
CR605856 T cells (Jurkat cell line) Cot10-normalized .d 47 to 1056 1 to 1010 exact     1010/1010
(100 %)
0 diff
(100 %id)
DB103691 thymus .e 1 to 549 2 to 551 G46W T47H I48H D49R V50C ... tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
BM927070 brain .e 90 to 1047 1 to 969   tiling clone,   969/1051
(92 %)
32 diff
(97.0 %id)
BE379742 bladder, carcinoma, cell line .e 133 to 1451 844 to 1   tiling clone,   719/908
(79 %)
16 diff
(98.3 %id)
DB342677 thymus .e 941 to 1528 589 to 1   tiling clone,   589/589
(100 %)
2 diff
(99.7 %id)
DB176858 kidney, tumor tissue .f-u 1 to 550 2 to 551 exact tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
DA415377 thalamus .f-u 6 to 638 2 to 636 exact tiling clone, capped   635/635
(100 %)
3 diff
(99.6 %id)
BP429004   .g -8 to 337 1 to 346 exact tiling clone,   346/346
(100 %)
2 diff
(99.5 %id)
DW425865 Liver .g 16 to 238 11 to 233 exact AAA   223/233
(95 %)
8 diff
(96.6 %id)
BU960938 mixed (pool of 40 RNAs) .g 30 to 269 1 to 240 exact AAA   240/240
(100 %)
2 diff
(99.2 %id)
CF597111 ovary .g 30 to 255 1 to 227 exact     227/250
(90 %)
11 diff
(95.6 %id)
CD685038 normal nasopharynx .g 33 to 237 17 to 221 exact     205/221
(92 %)
7 diff
(96.9 %id)
CD701249 normal nasopharynx .g 33 to 251 39 to 259 S9E E10R E12R     221/259
(85 %)
11 diff
(95.8 %id)
N87559   .g 35 to 342 1 to 301 exact     301/312
(96 %)
13 diff
(95.9 %id)
BE702387 nervous_normal Gene CETN2, variant not shown         This clone was ignored    
AV655130 corresponding non cancerous liver tissue Gene CETN2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BG566733 Liver Gene CETN2, variant not shown         Suspected internal deletion, this clone was ignored    
DB198812 trachea Gene CETN2, variant not shown       capped This clone was ignored    
DB348240 trachea Gene CETN2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI